Probiotics for treatment and primary prevention of allergic diseases and asthma: looking back and moving forward

Expert Review of Clinical Immunology

Volumn 12, Issue 6, 2016, Pages 625-639

  West, Christina E ^a,b   Jenmalm, Maria C ^a,c   Kozyrskyj, Anita L ^a,d   Prescott, Susan L ^a,e  

^a International Inflammation (in FLAME) network of the World Universities Network   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Diversity; dysbiosis; eczema; gut microbiome; hygiene hypothesis; primary prevention; probiotic

Indexed keywords

PROBIOTIC AGENT;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; DRUG EFFICACY; ECZEMA; FOOD ALLERGY; HUMAN; IMMUNE SYSTEM; INTESTINE FLORA; MATURATION; META ANALYSIS (TOPIC); NONHUMAN; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); ANIMAL; HYPERSENSITIVITY; MICROFLORA; MUCOSAL IMMUNITY; TRENDS;

ANIMALS; ASTHMA; HUMANS; HYPERSENSITIVITY; IMMUNITY, MUCOSAL; META-ANALYSIS AS TOPIC; MICROBIOTA; PRIMARY PREVENTION; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84961217412     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2016.1147955     Document Type: Review

References (100)

1. S.H.Podolsky Metchnikoff and the microbiome. The Lancet. 2012;24(380):1810–1811.
2. A.C.Logan, M.A.Katzman, V.Balanza-Martinez. Natural environments, ancestral diets, and microbial ecology: is there a modern “paleo-deficit disorder”? Part II. J Physiol Anthropol. 2015;34:9.
3. R.Dubos, R.W.Schaedler. Some biological effects of the digestive flora. Am J Med Sci. 1962;244:265–271.
4. S.L.Prescott. Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases. J Allergy Clin Immunol. 2013;131:23–30.
5. M.Blaser. Antibiotic overuse: Stop the killing of beneficial bacteria. Nature. 2011;476:393–394.
6. C.E.West, H.Renz, M.C.Jenmalm, et al. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. J Allergy Clin Immunol. 2015;135:3–13.
7. A.N.Thorburn, C.I.McKenzie, S.Shen, et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun. 2015;6:7320.•• In this experimental model, feeding mice a high-fiber diet induced a distinctive gut microbiota with higher levels of the short-chain fatty acid acetate. High fiber or acetate feeding led to marked suppression of allergic airways disease by enhanced T-regulatory cell numbers and function. In addition, high fiber/acetate feeding of pregnant mice suppressed the expression of certain genes in the mouse fetal lung linked to both human asthma and experimental allergic airways disease. The authors concluded that a diet influencing the gut microbiota may represent a strategy to prevent asthma, also in pregnancy.
8. Y.Belkaid, T.W.Hand. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121–141.
9. M.C.Jenmalm. Childhood immune maturation and allergy development: regulation by maternal immunity and microbial exposure. Am J Reprod Immunol. 2011;66 Suppl 1(Suppl 1):75–80.
10. C.E.West, M.C.Jenmalm, S.L.Prescott. The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy. 2015;45:43–53.
11. K.Aagaard, J.Ma, K.M.Antony, et al. The placenta harbors a unique microbiome. Sci Transl Med. 2014;6(237ra65).•• This study showed that low amounts of DNA from bacterial phyla are also found in the placenta of a healthy pregnancy and that these phyla are resembling those in the mouth and not the phyla present in closer anatomic regions, e.g. the vagina, gut, or on the skin.
12. L.J.Funkhouser, S.R.Bordenstein. Mom knows best: the universality of maternal microbial transmission. PLoS Biol. 2013;11:e1001631.
13. M.J.Stout, B.Conlon, M.Landeau, et al. Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J Obstet Gynecol. 2013;208(3):226.e1-7.
14. T.R.Abrahamsson, R.Y.Wu, M.C.Jenmalm. Gut microbiota and allergy: the importance of the pregnancy period. Pediatr Res. 2015;77:214–219.
15. E.Jimenez, L.Fernandez, M.L.Marin, et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol. 2005;51:270–274.
16. M.B.Azad, T.Konya, H.Maughan, et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. Cmaj. 2013;185:385–394.
17. M.B.Azad, T.Konya, R.R.Persaud, et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. Bjog. 2015 [Sep28]; [Epub ahead of print].• This article documented altered gut microbial composition in full-term infants following intrapartum antibiotic prophylaxis, especially with emergency cesarean delivery. This dysbiosis persisted at 1 year of age only among infants who were not exclusively breastfed at age 3 months.
18. F.Bäckhed, J.Roswall, Y.Peng, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17:690–703.•• This study assessed the gut microbiomes of mothers and their infants in their first year of life, showing that weaning induces maturation of the gut microbiota. Maturation of the infant gut microbiome was accompanied by shifts in nutrient and xenobiotic metabolism.
19. S.Dogra, O.Sakwinska, S.-E.Soh, et al. Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity. MBio. 2015;6(1):e02419-14.
20. H.E.Jakobsson, T.R.Abrahamsson, M.C.Jenmalm, et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut. 2014;63:559–566.• This study showed that children born through cesarean section had lower total microbiota diversity in infancy than vaginally delivered children. Persistent changes in the gut microbiota were demonstrated up to 2 years of age, particularly a decreased diversity of the Bacteroidetes phylum among cesarean-delivered children. Cesarean delivery was associated with a delayed maturation of Th1-associated immunity.
21. J.Penders, K.Gerhold, E.E.Stobberingh, et al. Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J Allergy Clin Immunol. 2013;132:601–7 e8.
22. F.A.Van Nimwegen, J.Penders, E.E.Stobberingh, et al. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol. 2011;128:948-55 e1-3.
23. P.Mastromarino, D.Capobianco, A.Miccheli, et al. Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery. Pharmacol Res. 2015;95-96:63–70.• This is the first article to show an alteration in breast milk lactobacilli and bifidobacteria with maternal probiotic treatment seen after vaginal but not cesarean delivery.
24. M.C.Jenmalm, B.Björkstén. Allergy, immunity and tolerance in early childhood: the first steps of the atopic March. Wahn U, Sampson HA, editors. Elsevier; 2016, p. 171–194.
25. P.-Y.Hong, B.W.Lee, M.Aw, et al. Comparative analysis of fecal microbiota in infants with and without eczema. PLoS One. 2010;5:e9964.
26. 9 CFU each daily) 6 weeks before delivery and then directly to infants for 12 months were evaluated up to 6 years of age in this study. The supplemented probiotic strains were detected in fecal samples during the intervention, but did not clearly affect gut microbiota composition and diversity. Interestingly, gut microbiota development continued between 2 and 6 years, then approaching a more adult-like composition.
27. I.Adlerberth, A.E.Wold. Establishment of the gut microbiota in Western infants. Acta Paediatr. 2009;98:229–238.
28. J.Cahenzli, Y.Koller, M.Wyss, et al. Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell Host Microbe. 2013;14:559–570.
29. N.Sudo, S.Sawamura, K.Tanaka, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 1997;159:1739–1745.
30. T.Olszak, D.An, S.Zeissig, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336:489–493.
31. D.An, S.F.Oh, T.Olszak, et al. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell. 2014;156:123–133.•• In this murine model, inhibitory sphingolipids from Bacteroides fragilis (B. fragilis) modified the homeostasis of host iNKT cells, effectively limiting iNKT cell proliferation during neonatal development and restricting total colonic iNKT cell numbers into adulthood. B. fragilis colonized hosts were protected against experimental iNKT cell-mediated, oxazolone-induced colitis. When germ-free pregnant dams were cohoused with B. fragilis monocolonized mice before delivery, the offspring’s colonic iNKT cell numbers were not normalized to the level observed when germ-free dams were mated with B. fragilis monocolonized mice, although at time of delivery, the mother was heavily colonized with B. fragilis bacteria. Thus, presence of B. fragilis during a prolonged prenatal period seemed to be required for achieving iNKT cell homeostasis.
32. S.El Aidy, G.Hooiveld, V.Tremaroli, et al. The gut microbiota and mucosal homeostasis: colonized at birth or at adulthood, does it matter? Gut Microbes. 2013;4:118–124.
33. M.Yamamoto, R.Yamaguchi, K.Munakata, et al. A microarray analysis of gnotobiotic mice indicating that microbial exposure during the neonatal period plays an essential role in immune system development. BMC Genomics. 2012;13:335.
34. C.H.Hansen, D.S.Nielsen, M.Kverka, et al. Patterns of early gut colonization shape future immune responses of the host. PLoS One. 2012;7:e34043.
35. M.C.Jenmalm, K.Duchen. Timing of allergy-preventive and immunomodulatory dietary interventions - are prenatal, perinatal or postnatal strategies optimal? Clin Exp Allergy. 2013;43:273–278.
36. E.Von Mutius, D.Vercelli. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol. 2010;10:861–868.
37. T.R.Abrahamsson, T.Jakobsson, M.F.Böttcher, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1174–1180.
38. C.K.Dotterud, O.Storro, R.Johnsen, et al. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol. 2010;163:616–623.
39. M.Kalliomäki, S.Salminen, H.Arvilommi, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357:1076–1079.
40. K.Kukkonen, E.Savilahti, T.Haahtela, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:192–198.
41. S.Rautava, E.Kainonen, S.Salminen, et al. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130:1355–1360.
42. K.Wickens, P.N.Black, T.V.Stanley, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008;122:788–794.
43. M.S.Abelius, E.Lempinen, K.Lindblad, et al. Th2-like chemokine levels are increased in allergic children and influenced by maternal immunity during pregnancy. Pediatr Allergy Immunol. 2014;25:387–393.
44. A.Forsberg, T.R.Abrahamsson, B.Björkstén, et al. Pre- and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin Exp Allergy. 2013;43:434–442.
45. A.Forsberg, T.R.Abrahamsson, B.Björkstén, et al. Pre- and postnatal administration of Lactobacillus reuteri decreases TLR2 responses in infants. Clin Transl Allergy. 2014;4:21.
46. R.J.Boyle, I.H.Ismail, S.Kivivuori, et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy. 2011;66:509–516.
47. M.R.Simpson, C.K.Dotterud, O.Storro, et al. Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial. BMC Dermatol. 2015;15:13.
48. M.Kalliomäki, S.Salminen, T.Poussa, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361:1869–1871.
49. M.Kalliomäki, S.Salminen, T.Poussa, et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1019–1021.
50. M.V.Kopp, I.Hennemuth, A.Heinzmann, et al. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008;121:e850–6.
51. M.Kuitunen, K.Kukkonen, K.Juntunen-Backman, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123:335–341.
52. T.R.Abrahamsson, T.Jakobsson, B.Björkstén, et al. No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Pediatr Allergy Immunol. 2013;24:556–561.
53. K.Wickens, P.Black, T.V.Stanley, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy. 2012;42:1071–1079.
54. K.Wickens, T.V.Stanley, E.A.Mitchell, et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy. 2013;43:1048–1057.
55. A.Huurre, K.Laitinen, S.Rautava, et al. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy. 2008;38:1342–1348.
56. L.Niers, R.Martin, G.Rijkers, et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy. 2009;64:1349–1358.
57. D.M.Gorissen, N.B.Rutten, C.M.Oostermeijer, et al. Preventive effects of selected probiotic strains on the development of asthma and allergic rhinitis in childhood. The Panda study. Clin Exp Allergy. 2014;44:1431–1433.
58. J.Y.Kim, J.H.Kwon, S.H.Ahn, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol. 2010;21:e386–93.
59. C.Y.Ou, H.C.Kuo, L.Wang, et al. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy. 2012;42:1386–1396.
60. S.J.Allen, S.Jordan, M.Storey, et al. Probiotics in the prevention of eczema: a randomised controlled trial. Arch Dis Child. 2014;99:1014–1019.
61. A.L.Taylor, J.A.Dunstan, S.L.Prescott. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119:184–191.
62. M.P.Jensen, S.Meldrum, A.L.Taylor, et al. Early probiotic supplementation for allergy prevention: long-term outcomes. J Allergy Clin Immunol. 2012;130:1209–11 e5.
63. S.E.Soh, M.Aw, I.Gerez, et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants–effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy. 2009;39:571–578.
64. E.X.Loo, G.V.Llanora, Q.Lu, et al. Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up. Int Arch Allergy Immunol. 2014;163:25–28.
65. C.E.West, M.-L.Hammarström, O.Hernell. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol. 2009;20:430–437.
66. C.E.West, M.-L.Hammarström, O.Hernell. Probiotics in primary prevention of allergic disease - follow-up at 8-9 years of age. Allergy. 2013;68:1015–1020.
67. C.E.West. Probiotics for allergy prevention. Benef Microbes. 2015 [Dec 21]; 1–10. [Epub ahead of print].
68. T.R.Abrahamsson, M.Sandberg Abelius, A.Forsberg, et al. A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. Clin Exp Allergy. 2011;41:1729–1739.
69. M.S.Abelius, J.Ernerudh, G.Berg, et al. High cord blood levels of the T-helper 2-associated chemokines CCL17 and CCL22 precede allergy development during the first 6 years of life. Pediatr Res. 2011;70:495–500.
70. M.Fagerås, S.Tomicic, T.Voor, et al. Slow salivary secretory IgA maturation may relate to low microbial pressure and allergic symptoms in sensitized children. Pediatr Res. 2011;70:572–577.
71. C.E.West, P.Rydén, D.Lundin, et al. Gut microbiome and innate immune response patterns in IgE-associated eczema. Clin Exp Allergy. 2015;45:1419–1429.• In this study, reduced relative abundance of tolerance-associated gut bacteria, e.g. Proteobacteria and Ruminoccoccaceae, was seen in infants developing IgE-associated eczema compared with infants that remained nonallergic. The reduction of these gut bacteria was associated with exaggerated innate immune responses and higher production of inflammatory biomarkers.
72. T.R.Abrahamsson, H.E.Jakobsson, A.F.Andersson, et al. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol. 2012;129:434-40, 40 e1-2.
73. T.R.Abrahamsson, H.E.Jakobsson, A.F.Andersson, et al. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy. 2014;44:842–850.• In this study, children with asthma at school age had a lower diversity of the total microbiota at 1 week and 1 month of age compared with nonasthmatic children. A similar association was not found for allergic rhinoconjunctivitis, although both these findings should be confirmed in larger studies. The authors speculated that a less diverse microbial stimulation could have resulted in a reduced mucosal barrier function, leading to increased airway viral infection susceptibility, amplification of Th2 responses, and subsequent asthma development.
74. M.C.Arrieta, L.T.Stiemsma, P.A.Dimitriu, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7:307ra152.•• In this study, the gut microbiome of 319 infants was assessed. Infants at risk of asthma demonstrated transient gut microbial dysbiosis in the first 100 days of life with lower relative abundance of Lachnospira, Veillonella, Faecalibacterium, and Rothia. This occurred in conjunction with reduced acetate levels in stool and dysregulation of enterohepatic metabolites. When germ-free mice were inoculated with these four taxa, reduced airway inflammation in their adult offspring was seen, suggesting a role of these taxa in preventing asthma. Neutrophilic but not eosinophilic infiltration was attenuated by the inoculation, possibly questioning the relevance for human pediatric asthma, which is typically eosinophilia-dominated.
75. C.K.Dotterud, E.Avershina, M.Sekelja, et al. Does maternal perinatal probiotic supplementation alter the intestinal microbiota of mother and child? A randomized controlled trial. J Pediatr Gastroenterol Nutr. 2015;61:200–207.• Intake of a probiotic combination in pregnancy and during breastfeeding reduced the incidence of eczema in childhood, and in this study, it was shown that only one of the administered strains, L. rhamnosus GG, increased in the infant’s stool during the intervention. This suggests that specific probiotic strains are more apt to transfer from mother to child.
76. H.Majamaa, E.Isolauri. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;99:179–185.
77. E.Isolauri, T.Arvola, Y.Sutas, et al. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30:1604–1610.
78. R.J.Boyle, F.J.Bath-Hextall, J.Leonardi-Bee, et al. Probiotics for treating eczema. Cochrane Database Syst Rev. 2008;4:CD006135.
79. S.O.Kim, Y.M.Ah, Y.M.Yu, et al. Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol. 2014;113:217–226.
80. K.L.Baquerizo Nole, E.Yim, J.E.Keri. Probiotics and prebiotics in dermatology. J Am Acad Dermatol. 2014;71:814–821.
81. T.Biedermann, Y.Skabytska, S.Kaesler, et al. Regulation of T cell immunity in atopic dermatitis by microbes: the Yin and Yang of cutaneous inflammation. Front Immunol. 2015;6:353.
82. J.Hol, E.H.Van Leer, B.E.Elink Schuurman, et al. The acquisition of tolerance toward cow’s milk through probiotic supplementation: a randomized, controlled trial. J Allergy Clin Immunol. 2008;12:1448–1454.
83. R.Berni Canani, R.Nocerino, G.Terrin, et al. Effect of Lactobacillus GG on tolerance acquisition in infants with cow’s milk allergy: a randomized trial. J Allergy Clin Immunol. 2012;129:580-2, 2 e1-5.
84. A.Nowak-Wegrzyn, Y.Katz, S.S.Mehr, et al. Non-IgE-mediated gastrointestinal food allergy. J Allergy Clin Immunol. 2015;135:1114–1124.
85. M.L.Tang, A.L.Ponsonby, F.Orsini, et al. Administration of a probiotic with peanut oral immunotherapy: A randomized trial. J Allergy Clin Immunol. 2015;135:737–44 e8.• Compared with placebo, the combination of peanut oral immunotherapy and intake of a probiotic L. rhamnosus strain induced desensitization at a much higher rate. This interesting observation should be evaluated using a three-arm design to examine if the benefit of the combined peanut and probiotic therapy is superior to peanut oral immunotherapy alone.
86. A.E.Zajac, A.S.Adams, J.H.Turner. A systematic review and meta-analysis of probiotics for the treatment of allergic rhinitis. Int Forum Allergy Rhinol. 2015;5:524–532.
87. H.Vliagoftis, V.D.Kouranos, G.I.Betsi, et al. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol. 2008;101:570–579.
88. C.A.Cuello-Garcia, J.L.Brozek, A.Fiocchi, et al. Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2015;136:952–961.
89. G.Zuccotti, F.Meneghin, A.Aceti, et al. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy. 2015;70:1356–1371.
90. A.Fiocchi, W.Burks, S.L.Bahna, et al. Clinical use of probiotics in pediatric allergy (CUPPA): A world allergy organization position paper. World Allergy Organ J. 2012;5:148–167.
91. A.Muraro, I.Agache, A.Clark, et al. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community. Allergy. 2014;69:1046–1057.
92. M.B.Azad, J.G.Coneys, A.L.Kozyrskyj, et al. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. Bmj. 2013;347:f6471.
93. R.J.Bertelsen, A.L.Brantsaeter, M.C.Magnus, et al. Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases. J Allergy Clin Immunol. 2014;133:165-71 e1-8.•• In this large population-based Norwegian cohort study MoBa, the reported intake of probiotic milk products in pregnancy and infancy was associated with a reduced incidence of eczema and rhinocinjunctivitis, but not asthma, at 3 years of age.
94. T.R.Abrahamsson, G.Sinkiewicz, T.Jakobsson, et al. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J Pediatr Gastroenterol Nutr. 2009;49:349–354.
95. H.K.Opoien, A.Valbo, A.Grinde-Andersen, et al. Post-cesarean surgical site infections according to CDC standards: rates and risk factors. A prospective cohort study. Acta Obstet Gynecol Scand. 2007;86:1097–1102.
96. A.Fiocchi, R.Pawankar, C.Cuello-Garcia, et al. World allergy organization-mcmaster university guidelines for allergic disease prevention (GLAD-P): probiotics. World Allergy Organ J. 2015;8:4.
97. G.H.Guyatt, A.D.Oxman, R.Kunz, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64:395–400.
98. C.E.West, S.L.Prescott. Prebiotics and probiotics for prevention of allergic disease [Internet]. In: UptoDate, D.Basedow, editor. Waltham, MA: UptoDate; 2015. [cited 2015 Oct 10]. Available from: http://www.uptodate.com/contents/prebiotics-and-probiotics-for-prevention-of-allergic-disease.
99. D.J.Jackson, T.V.Hartert, F.D.Martinez, et al. Asthma: NHLBI workshop on the primary prevention of chronic lung diseases. Ann Am Thorac Soc. 2014;11 Suppl 3(Suppl 3):S139–45.
100. FAO/WHO. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. World Health Organization, London Ontario, Canada. 2002.